We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$53.3B
AUM Growth
+$1.63B
Cap. Flow
-$179M
Cap. Flow %
-0.34%
Top 10 Hldgs %
17.17%
Holding
3,102
New
155
Increased
2,027
Reduced
775
Closed
131

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$67.7M
2
CTVA icon
Corteva
CTVA
+$33.4M
3
TCF
TCF Financial Corporation Common Stock
TCF
+$19.3M
4
SPOT icon
Spotify
SPOT
+$15.3M
5
AMCR icon
Amcor
AMCR
+$15M

Sector Composition

Rank Sector Weight
1 Technology 18.25%
2 Financials 15.55%
3 Healthcare 13.39%
4 Consumer Discretionary 10.43%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRRX
2976
DELISTED
DURECT Corp
DRRX
-20,060
Closed -$126K
DWSN icon
2977
Dawson Geophysical
DWSN
$145M
-29,510
Closed -$86K
FBIO icon
2978
Fortress Biotech
FBIO
$104M
-2,953
Closed -$79K
FCEL icon
2979
FuelCell Energy
FCEL
$1.73B
-309
Closed -$27K
FENC icon
2980
Fennec Pharmaceuticals
FENC
$332M
-13,375
Closed -$65K
FRO icon
2981
Frontline
FRO
$8.76B
-109,190
Closed -$705K
GYRE icon
2982
Gyre Therapeutics
GYRE
$641M
-2,243
Closed -$136K
HBB icon
2983
Hamilton Beach Brands
HBB
$311M
-9,540
Closed -$205K
HBIO icon
2984
Harvard Bioscience
HBIO
$27.5M
-4,864
Closed -$210K
HSDT icon
2985
Solana Company
HSDT
$96.3M
0
-$138K
IBRX icon
2986
ImmunityBio
IBRX
$7.51B
-38,052
Closed -$60K
IJK icon
2987
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
-9,204
Closed -$504K
IMUX icon
2988
Immunic
IMUX
$190M
-90
Closed -$7K
IWN icon
2989
iShares Russell 2000 Value ETF
IWN
$14.3B
-9,688
Closed -$1.16M
IWP icon
2990
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
-18,944
Closed -$1.28M
IWR icon
2991
iShares Russell Mid-Cap ETF
IWR
$56B
-13,474
Closed -$727K
KINS icon
2992
Kingstone Companies
KINS
$289M
-12,484
Closed -$184K
KODK icon
2993
Kodak
KODK
$822M
-22,106
Closed -$65K
LRMR icon
2994
Larimar Therapeutics
LRMR
$397M
-3,226
Closed -$106K
KG
2995
Kestrel Group
KG
$69.4M
-4,789
Closed -$71K
NXPI icon
2996
NXP Semiconductors
NXPI
$57.8B
-326,966
Closed -$28.9M
OEF icon
2997
iShares S&P 100 ETF
OEF
$20.1B
-4,977
Closed -$624K
ORN icon
2998
Orion Group Holdings
ORN
$396M
-81,356
Closed -$238K
OVID icon
2999
Ovid Therapeutics
OVID
$414M
-17,010
Closed -$30K
RAIL icon
3000
FreightCar America
RAIL
$261M
-17,960
Closed -$111K

Similar funds

RhumbLine Advisers's Q2 2019 Portfolio in Review

As of Q2 2019, RhumbLine Advisers held 3,102 positions worth $53.3B, up 3.2% from $51.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

RhumbLine Advisers's Q2 2019 filing shows 155 new, 2,027 increased, 775 reduced and 131 closed positions. Its largest new stake was Dow Inc: 1,282,896 shares worth $63.3M. The largest sale was DuPont de Nemours, an estimated $62.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2019 buy was Dow Inc: 1,282,896 shares worth $63.3M.
  • RhumbLine Advisers added most to TCF Financial Corporation Common Stock in Q2 2019, an estimated $19.3M increase.
  • RhumbLine Advisers's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $62.6M.
  • RhumbLine Advisers fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $29.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $53.3B portfolio in Q2 2019.
  • RhumbLine Advisers opened 155 new positions and closed 131 in Q2 2019.
  • RhumbLine Advisers's portfolio value rose 3.2% quarter-over-quarter to $53.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.